Source: Investing.com ↗

Inhibrx director Jon Kayyem buys $567,580 in company stock

|

Translation unavailable. Please try again.

Original report

Read the original report on Investing.com ↗

Recommended markets

No specific asset was identified in this report; browse live USDT reference pairs.

Browse markets →

USDC/USDT

$1.00

-0.01%

BTC/USDT

$85,596.00

-0.63%

ETH/USDT

$2,728.04

-0.83%

ZEC/USDT

$1,637.53

+6.63%

XRP/USDT

$1.57

+1.69%